Showing search results for

Privo announces $2M FDA award for oral cancer product clinical study

Boston — The US Food and Drug Administration (FDA) had previously granted Privo Technologies’ (Privo) an IND to study PRV111, its nano-engineered chemotherapy and immunomodulatory product, in patients with oral cancer (NCT03502148). Today, Privo is excited to announce that it has been awarded ~ $2 million in funding from the FDA through its Office of Orphan Product Development […]

Inkbit raises $12M in equity round to enable high-volume production of precision multi-material parts

New treatment from Deshpande-backed research could ease passage of kidney stones

Johnson & Johnson acquires TARIS Biomedical with focus on transforming treatment of bladder cancer

Sikes Lab, supported by Deshpande Center, collaborates with 3M to develop rapid Covid-19 test

Glympse Bio announces $46.7M Series B financing, supporting development of novel biosensor platform in NASH patients

Deshpande spinout Glympse Bio works on faster tracking of treatment responses

Deshpande project shows mucus contains sugar molecules that tame microbes

Double-sided tape for tissues could replace surgical sutures, Deshpande-backed project shows


1 2 56 57 58 59 60